Document/ExhibitDescriptionPagesSize 1: 10-Q 10-Q (Q2 2022) HTML 4.44M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 26K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
4: EX-31.3 Certification -- §302 - SOA'02 HTML 26K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
11: R1 Cover HTML 79K
12: R2 Condensed Consolidated Balance Sheets HTML 123K
13: R3 Condensed Consolidated Balance Sheets HTML 51K
(Parenthetical)
14: R4 Condensed Consolidated Statements of Operations HTML 105K
15: R5 Condensed Consolidated Statements of Comprehensive HTML 91K
Income (Loss)
16: R6 Condensed Consolidated Statements of Shareholders' HTML 60K
Equity
17: R7 Condensed Consolidated Statements Of Shareholders' HTML 24K
Equity (Parenthetical)
18: R8 Condensed Consolidated Statements of Cash Flows HTML 84K
19: R9 Significant Accounting Policies HTML 28K
20: R10 New Accounting Standards HTML 45K
21: R11 Supplemental Information about Changes to HTML 125K
Accumulated Other Comprehensive Income
22: R12 Investments HTML 558K
23: R13 Commitments and Contingencies HTML 30K
24: R14 Liability for Unpaid Claims HTML 41K
25: R15 Postretirement Benefits HTML 129K
26: R16 Earnings Per Share HTML 35K
27: R17 Debt HTML 80K
28: R18 Business Segments HTML 421K
29: R19 Significant Accounting Policies (Policies) HTML 29K
30: R20 Supplemental Information About Changes to HTML 125K
Accumulated Other Comprehensive Income (Tables)
31: R21 Investments (Tables) HTML 575K
32: R22 Liability for Unpaid Claims (Tables) HTML 44K
33: R23 Postretirement Benefits (Tables) HTML 131K
34: R24 Earnings Per Share (Tables) HTML 34K
35: R25 Debt (Tables) HTML 72K
36: R26 Business Segments (Tables) HTML 411K
37: R27 Significant Accounting Policies - Business HTML 23K
(Details)
38: R28 New Accounting Standards (Details) HTML 50K
39: R29 Supplemental Information about Changes to HTML 55K
Accumulated Other Comprehensive Income - Schedule
of Change in Balance by Component (Detail)
40: R30 Supplemental Information about Changes to HTML 66K
Accumulated Other Comprehensive Income - Summary
of Reclassifications (Detail)
41: R31 Investments - Summary of Fixed Maturities HTML 92K
Available for Sale by Component (Detail)
42: R32 Investments - Schedule of Fixed Maturities by HTML 56K
Contractual Maturity (Detail)
43: R33 Investments - Schedule of Analysis of Investment HTML 48K
Operations (Detail)
44: R34 Investments - Schedule of Selected Information HTML 32K
about Sales of Fixed Maturities (Detail)
45: R35 Investments - Realized Gain (Loss) on Investments HTML 40K
(Detail)
46: R36 Investments - Assets Measured at Fair Value on HTML 105K
Recurring Basis (Detail)
47: R37 Investments - Schedule of Changes in Assets HTML 63K
Measured at Fair Value on a Recurring Basis Using
Significant Unobservable Inputs (Level 3) (Detail)
48: R38 Investments - Unrealized Gains or (Losses) HTML 31K
Included in Other Comprehensive Income (Details)
49: R39 Investments - Information about Investments in HTML 33K
Unrealized Loss Position (Detail)
50: R40 Investments - Schedule of Unrealized Investment HTML 114K
Losses by Class of Investment (Detail)
51: R41 Investments - Fixed Maturities, Allowance for HTML 37K
Credit Loss (Details)
52: R42 Investments - Schedule of Other Long-Term HTML 31K
Investments (Detail)
53: R43 Investments - Schedule of Investment Funds HTML 43K
(Details)
54: R44 Investments - Commercial Mortgage Loan HTML 79K
Participations (Details)
55: R45 Investments - Commercial Mortgage Loan HTML 63K
Participations, Internal Credit Assessment
(Details)
56: R46 Investments - Commercial Mortgage Loan HTML 34K
Participations, Allowance for Credit Loss
(Details)
57: R47 Investments - Additional Information (Detail) HTML 37K
58: R48 Commitments and Contingencies (Details) HTML 27K
59: R49 Liability for Unpaid Claims - Summary of Liability HTML 44K
for Unpaid Health Claims (Details)
60: R50 Liability for Unpaid Claims - Reconciliation of HTML 29K
Net Incurred and Paid Claims Development to
Liability (Details)
61: R51 Postretirement Benefits - Pension Assets by HTML 111K
Components at Fair Value (Detail)
62: R52 Postretirement Benefits - Activity for the SERP HTML 31K
(Detail)
63: R53 Postretirement Benefits - Pension and SERP HTML 31K
Liabilities (Details)
64: R54 Postretirement Benefits - Components of Net HTML 41K
Periodic Pension Costs (Detail)
65: R55 Earnings Per Share (Details) HTML 32K
66: R56 Debt - Additional Information (Details) HTML 61K
67: R57 Debt - Selected Information about Debt Issues HTML 101K
(Detail)
68: R58 Business Segments - Segment Premium Income by HTML 85K
Distribution Channel and Additional Information
(Detail)
69: R59 Business Segments - Reconciliation of Segment HTML 147K
Operating Information to Consolidated Statement of
Operations (Detail)
72: XML IDEA XML File -- Filing Summary XML 135K
70: XML XBRL Instance -- gl-20220630_htm XML 5.97M
71: EXCEL IDEA Workbook of Financial Reports XLSX 170K
7: EX-101.CAL XBRL Calculations -- gl-20220630_cal XML 251K
8: EX-101.DEF XBRL Definitions -- gl-20220630_def XML 842K
9: EX-101.LAB XBRL Labels -- gl-20220630_lab XML 1.79M
10: EX-101.PRE XBRL Presentations -- gl-20220630_pre XML 1.09M
6: EX-101.SCH XBRL Schema -- gl-20220630 XSD 176K
73: JSON XBRL Instance as JSON Data -- MetaLinks 476± 725K
74: ZIP XBRL Zipped Folder -- 0000320335-22-000026-xbrl Zip 1.04M
(Exact name of registrant as specified in its charter)
iDelaware
i63-0780404
(State
or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
i3700 South Stonebridge Drive, iMcKinney, iTexasi75070
(Address of principal executive offices) (Zip Code)
(i972) i569-4000
(Registrant’s telephone number, including area code)
NONE
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon
Stock, $1.00 par value per share
iGL
iNew York Stock Exchange
i4.250%
Junior Subordinated Debentures
iGL PRD
iNew York Stock Exchange
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. iYes☒ No ☐
Indicate by check mark whether the
registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). iYes☒ No ☐
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,”“accelerated filer,”“smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
iLarge
accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
i☐
Emerging
growth company
i☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No i☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As
used in this Form 10-Q, “Globe Life,” the “Company,”“we,”“our” and “us” refer to Globe Life Inc., a Delaware corporation incorporated in 1979, its subsidiaries and affiliates.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
iNote
1—Significant Accounting Policies
Business: (Globe Life), (the Company), refers to Globe Life Inc., an insurance holding company incorporated in Delaware in 1979, and Globe Life Inc. subsidiaries and affiliates. Globe Life Inc.'s direct or indirect primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American
Insurance Company. The underwriting companies are owned by their ultimate corporate parent, Globe Life Inc. (the Parent Company).
Globe Life provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The Company is organized into ifour reportable segments: life insurance, supplemental health insurance, annuities, and investments.
iBasis
of Presentation: The accompanying consolidated financial statements of Globe Life have been prepared in accordance with the instructions to Form 10-Q. Therefore, they do not include all of the disclosures required by accounting principles generally accepted in the United States of America (GAAP) for annual financial statements. However, in the opinion of management, these statements include all adjustments, consisting of normal recurring adjustments, which are necessary for a fair presentation of the consolidated financial position at June 30, 2022, and the consolidated results of operations, comprehensive income, and cash flows for the periods ended June 30, 2022 and 2021. The interim period consolidated financial statements should be read in conjunction with the Consolidated
Financial Statements that are included in the Form 10-K filed with the Securities Exchange Commission (SEC) on February 24, 2022.
iUse of Estimates: The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimates. See further documentation in the significant accounting policies or the accompanying notes.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
iNote
2—New Accounting Standards
Accounting Pronouncements Yet to be Adopted
ASU No. 2018-12 / 2019-09 / 2020-11, Financial Services - Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts, with clarification guidance issued in November 2019 and 2020.
ASU 2018-12 is a significant change to the accounting and disclosure of long-duration life and health insurance contracts.
The guidance was issued primarily to: 1) improve the timeliness of recognizing changes in the liability for future policy benefits and modify the rate used to discount future cash flows, 2) simplify and improve the accounting for certain market-based options or guarantees associated with deposit (or account balance) contracts, 3) simplify the amortization of deferred acquisition costs, and 4) improve the effectiveness of the required disclosures.
As a result of the issuance of ASU 2020-11 in November 2020, the effective date for this standard was changed to January 1, 2023. Early adoption is available; however, the Company will not early adopt the standard and has
selected the modified retrospective transition method upon adoption as of the transition date (“Transition Date”) of January 1, 2021. The modified retrospective transition method requires the amended guidance be applied to contracts issued after the beginning of the earliest period presented, or the Transition Date, which will result in the restatement of the 2021 and 2022 consolidated financial statements.
In summary, the Company continues to assess the impact the adoption will have on the consolidated financial statements and has determined it will have a significant impact on the Consolidated Balance Sheets, Consolidated Statements of Operations, Consolidated
Statements of Shareholders’ Equity, and the Consolidated Statements of Comprehensive Income (Loss). On a quarterly basis, the Company’s future policy benefits will be remeasured utilizing an upper-medium grade fixed income instrument yield and the effects of the change will be recognized in Accumulated Other Comprehensive Income (“AOCI”), a component of shareholders’ equity. At least annually, the Company will update its estimate of cash flows used for establishing reserves using actual historical experience and updated future cash flow assumptions, such as mortality, morbidity, and persistency. Finally, the adoption requires changes in the future treatment of our Deferred Acquisition Cost (“DAC”) asset and is expected to result in a significant reduction to DAC amortization in the near
to intermediate term.
On the Transition Date, the Company expects a significant decrease in AOCI due to the requirement to re-measure future policy benefits using a discount rate currently lower than what is used in valuing the future policy benefits under existing guidance. The methodology for determining current discount rates consists of constructing a discount rate curve intended to be reflective of the currency and tenor of the insurance liability cash flows. Discount rates reflect upper-medium grade fixed-income instrument yields, which generally consist of single-A rated fixed income instruments. The methodology is designed to prioritize observable inputs based on market data available in the local debt markets denominated in the same currency as the policies. For the discount rates applicable
to tenors for which the single-A debt market is not liquid or there is little or no observable market data, the Company will use estimation techniques consistent with the fair value guidance in ASC 820. It is important to note that the impact to AOCI is sensitive to the discount rate assumption and associated fluctuations.
On the Transition Date, using current discount rates applicable at that time, we expect the after-tax impact to AOCI to be a decrease in the range of $i7.5 billion
to $i8.5 billion due to a $i9.5 billion
to $i11.0 billion increase in future policy benefits. Holding all else equal but using discount rates as of June 30, 2022, the increase in future policy benefits would have been $i3.0 billion
to $i4.0 billion. The impact on AOCI would reflect the impact of both the change in future policy benefits and the change in the fair value of invested assets. Under the new standard, the future policy benefits recorded on the Consolidated Balance Sheets are different than those used in the determination of net income. Future policy benefits recorded within the Consolidated Balance Sheets are determined using current
discount rates as of the valuation date, while future policy benefits used for the determination of net income are determined using locked-in discount rates1 based on policy issue dates. On the Transition Date, two significant drivers of the increase in future policy benefits and decrease in AOCI within the
1Locked-in discount rates are those discount rates which are established at issue and locked-in for each year of issue for use in establishing reserves to compute net income.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Consolidated Balance Sheets are the lower level of current discount rates as compared to the locked-in discount rates used under prior guidance and the long average life of the Company’s life insurance cash flows. Another driver of the large increase in future policy benefits is the required use of the same net premium ratio2 using locked-in discount rates and current discount rates.
The new guidance requires a more granular assessment of the
net premium ratio. Any blocks of business that require increases in future policy benefits to minimum levels, or that have a net premium ratio greater than 100%, will require an adjustment to the opening balance of retained earnings (decrease). At the Transition Date, we expect a $i15 million to $i50 million,
net of tax, decrease to opening retained earnings related to these items.
Under the new standard, the annual amortization of DAC in our Consolidated Statements of Operations will be significantly lower in the near and intermediate term due to: 1) the requirement to no longer defer renewal commissions until such year as the commissions are actually incurred, 2) the requirement to no longer accrue and amortize interest on our DAC balances, and 3) the modification of the method for amortizing DAC including the updating of assumptions. For business with deferrals of renewal commissions, as is the case with our captive agency channels, the expected amortization rate, as a percentage of premium, for certain blocks of business will no longer be level but will increase over the period of time during which commissions are deferred. The decrease in amortization in the near term will primarily
impact our life insurance line of business. In total, we expect the impact on net income from the decrease in amortization to be in the range of $i120 million to $i145 million,
net of tax. As time progresses, we expect this impact to diminish as the deferral of future renewal commissions increases amortization amounts.
Policyholder benefits, as reported in our Consolidated Statement of Operations, will be restated in 2021 and 2022 under the new guidance. It is expected to be lower in 2021 and 2022, resulting in higher net income for those respective periods than under the current guidance. Going forward, fluctuations in experience and changes in assumptions will result in changes in both future policy obligations and amortization of DAC as a percent of premium.
While the requirements of the new guidance represent a significant change from existing GAAP, the new guidance will not impact capital and surplus or net income under statutory accounting practices, cash flows on our
policies, or the underlying economics of our business.
ASU No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions
ASU 2022-03 adds disclosure requirements specific to equity securities subject to contractual sale restrictions. The disclosures clarify the nature of the contractual sale as well as the duration of the restriction and the circumstances that could cause a lapse in the restriction.
This standard is effective for the Company on January 1, 2024, and will
be implemented on a prospective basis. Early adoption is available. The Company does not expect the standard will have a material impact on the Consolidated Financial Statements.
2The net premium ratio is the ratio between the present value of benefits and the present value of gross premium.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
iNote 3—Supplemental Information about Changes to Accumulated Other Comprehensive Income
Components
of Accumulated Other Comprehensive Income: iAn analysis of the change in balance by component of Accumulated Other Comprehensive Income is as follows for the three and six month periods ended June 30, 2022 and 2021:
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Reclassification Adjustments: iReclassification
adjustments out of Accumulated Other Comprehensive Income are presented below for the three and six month periods ended June 30, 2022 and 2021.
Three
Months Ended June 30,
Six Months Ended June 30,
Affected line items in the Statement of Operations
Component Line Item
2022
2021
2022
2021
Unrealized investment (gains) losses on available for sale assets:
Realized
(gains) losses
$
i22,422
$
(i866)
$
i17,485
$
(i19,656)
Realized
(gains) losses
Amortization of (discount) premium
(i163)
i1,511
i744
i3,159
Net
investment income
Total before tax
i22,259
i645
i18,229
(i16,497)
Tax
(i4,674)
(i135)
(i3,828)
i3,464
Income
taxes
Total after-tax
i17,585
i510
i14,401
(i13,033)
Pension
adjustments:
Amortization of prior service cost
i158
i158
i316
i316
Other
operating expense
Amortization of actuarial (gain) loss
i3,283
i5,042
i6,562
i10,084
Other
operating expense
Total before tax
i3,441
i5,200
i6,878
i10,400
Tax
(i723)
(i1,094)
(i1,445)
(i2,185)
Income
taxes
Total after-tax
i2,718
i4,106
i5,433
i8,215
Total
reclassification (after-tax)
$
i20,303
$
i4,616
$
i19,834
$
(i4,818)
iNote 4—Investments
Portfolio Composition: iSummaries
of fixed maturities available for sale by amortized cost, fair value, and allowance for credit losses at June 30, 2022 and December 31, 2021, and the corresponding amounts of gross unrealized gains and losses recognized in accumulated other comprehensive income (loss) are as follows. Redeemable preferred stock is included within "Corporates, by sector."
U.S. Government direct, guaranteed, and government-sponsored enterprises
$
i383,083
$
i—
$
i64,513
$
(i164)
$
i447,432
i2
States,
municipalities, and political subdivisions
i2,252,997
i—
i239,135
(i2,907)
i2,489,225
i12
Foreign
governments
i59,861
i—
i900
(i5,132)
i55,629
i—
Corporates,
by sector:
Financial
i4,569,160
(i387)
i907,741
(i9,349)
i5,467,165
i26
Utilities
i1,931,391
i—
i490,119
(i1,012)
i2,420,498
i11
Energy
i1,587,892
i—
i346,780
(i1,683)
i1,932,989
i9
Other
corporate sectors
i6,879,459
i—
i1,454,464
(i13,362)
i8,320,561
i39
Total
corporates
i14,967,902
(i387)
i3,199,104
(i25,406)
i18,141,213
i85
Collateralized
debt obligations
i36,468
i—
i27,037
i—
i63,505
i—
Other
asset-backed securities
i104,998
i—
i3,715
(i430)
i108,283
i1
Total
fixed maturities
$
i17,805,309
$
(i387)
$
i3,534,404
$
(i34,039)
$
i21,305,287
i100
(1)Amount
reported in the balance sheet.
(2)At fair value.
i
A schedule of fixed maturities available for sale by contractual maturity date at June 30, 2022, is shown below on an amortized cost basis, net of allowance for credit losses, and on a fair value basis. Actual disposition dates could differ from contractual maturities due to call or prepayment
provisions.
(1)For
the three months ended June 30, 2022 and 2021, the investment funds, accounted for under the fair value option method, recorded $i8.6 million and $i6.5
million of distributions, respectively, in net investment income. For the six months ended June 30, 2022 and 2021, the investment funds, accounted for under the fair value option method, recorded $i19.3 million and $i12.3
million of distributions, respectively, in net investment income. Refer to Other Long-Term Investmentsbelowfor further discussion on the investment funds.
i
Selected information about sales of fixed maturities available for sale is as follows:
(1)During
the three months ended June 30, 2022 and 2021, the Company recorded $i1.9 million and $i22.4
million of exchanges of fixed maturities (noncash transactions) that resulted in $i0 and $i0, respectively, in
realized gains (losses). During the six months ended June 30, 2022 and 2021, the Company recorded $i1.9 million and $i108.3
million of exchanges of fixed maturities (noncash transactions) that resulted in $i0 and $i25.2
million, respectively, in realized gains (losses).
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Fair
Value Measurements:iThe following tables represent the fair value of fixed maturities measured on a recurring basis at June 30, 2022 and December 31, 2021:
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
i
The
following tables represent changes in fixed maturities measured at fair value on a recurring basis using significant unobservable inputs (Level 3):
Analysis of Changes in Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
(1)Includes
capitalized interest, foreign exchange adjustments, and principal repayments.
(2)Considered to be transferred at the end of the period. Transfers into Level 3 occur when observable inputs are no longer available. Transfers out of Level 3 occur when observable inputs become available.
Analysis
of Changes in Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
(1)Includes
capitalized interest, foreign exchange adjustments, and principal repayments.
(2)Considered to be transferred at the end of the period. Transfers into Level 3 occur when observable inputs are no longer available. Transfers out of Level 3 occur when observable inputs become available.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The following table presents changes in unrealized gains or losses for the period included in other comprehensive income for assets held at the end of the reporting period for Level 3s:
Changes
in Unrealized Gains (Losses) included in Other Comprehensive Income for Assets Held at the End of the Period
Globe
Life's entire fixed maturity portfolio consisted of i2,177 issues by i923 different issuers at June
30, 2022 and i2,060 issues by i843 different issuers at December 31, 2021. The weighted-average
quality rating of all unrealized loss positions at amortized cost was A- as of June 30, 2022 and December 31, 2021.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
The
following tables disclose unrealized investment losses by class and major sector of fixed maturities available for sale at June 30, 2022 and December 31, 2021.
U.S. Government direct, guaranteed, and government-sponsored enterprises
$
i289,383
$
(i7,858)
$
i3,465
$
(i580)
$
i292,848
$
(i8,438)
States,
municipalities and political subdivisions
i1,674,505
(i386,550)
i4,066
(i2,081)
i1,678,571
(i388,631)
Foreign
governments
i9,838
(i1,254)
i23,380
(i8,429)
i33,218
(i9,683)
Corporates,
by sector:
Financial
i2,260,544
(i284,797)
i50,713
(i14,674)
i2,311,257
(i299,471)
Utilities
i650,822
(i65,538)
i3,970
(i1,530)
i654,792
(i67,068)
Energy
i662,038
(i57,153)
i—
i—
i662,038
(i57,153)
Other
corporate sectors
i3,859,625
(i438,608)
i53,633
(i21,941)
i3,913,258
(i460,549)
Total
corporates
i7,433,029
(i846,096)
i108,316
(i38,145)
i7,541,345
(i884,241)
Collateralized
debt obligations
i—
i—
i—
i—
i—
i—
Other
asset-backed securities
i74,578
(i1,813)
i—
i—
i74,578
(i1,813)
Total
investment grade securities
i9,481,333
(i1,243,571)
i139,227
(i49,235)
i9,620,560
(i1,292,806)
Below
investment grade securities:
States, municipalities and political subdivisions
i—
i—
i—
i—
i—
i—
Corporates,
by sector:
Financial
i79,869
(i10,269)
i43,105
(i12,543)
i122,974
(i22,812)
Utilities
i28,547
(i2,350)
i—
i—
i28,547
(i2,350)
Energy
i48,666
(i8,428)
i19,176
(i8,896)
i67,842
(i17,324)
Other
corporate sectors
i162,448
(i19,219)
i6,999
(i4,342)
i169,447
(i23,561)
Total
corporates
i319,530
(i40,266)
i69,280
(i25,781)
i388,810
(i66,047)
Collateralized
debt obligations
i—
i—
i—
i—
i—
i—
Other
asset-backed securities
i—
i—
i12,493
(i617)
i12,493
(i617)
Total
below investment grade securities
i319,530
(i40,266)
i81,773
(i26,398)
i401,303
(i66,664)
Total
fixed maturities
$
i9,800,863
$
(i1,283,837)
$
i221,000
$
(i75,633)
$
i10,021,863
$
(i1,359,470)
Gross
unrealized losses may fluctuate quarter over quarter due to adverse factors in the market that affect our holdings, such as changes in interest rates or credit spreads. The Company considers many factors when determining whether an allowance for a credit loss should be recorded. While the Company holds securities that may be in an unrealized loss position from time to time, Globe Life does not generally intend to sell and it is likely that management will not be required to sell the fixed maturities prior to their anticipated recovery or maturity due to the strong cash flows generated by its insurance operations.
Fully
redeemable and non-redeemable with varying terms.
Opportunistic credit
i168,287
i178,215
i—
Initial
i2 year lock on each new investment/semi-annual withdrawals thereafter/full redemption within i36
month period.
Other
i154,277
i38,272
i146,367
Total
investment funds
$
i740,006
$
i640,263
$
i510,219
/
The
Company had $i143 million of capital called during the year from existing investment funds. Our unfunded commitments were $i510
million as of June 30, 2022.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Commercial Mortgage Loan Participations (commercial
mortgage loans):iSummaries of commercial mortgage loans by property type and geographical location at June 30, 2022 and December 31, 2021 are as follows:
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
i
The following tables are reflective of Management's internal risk ratings of the
loan portfolio. Loans are rated low, moderate, and high. The risk categories consider many different factors such as quality of asset, borrower status, as well as macroeconomic factors including COVID-19. These loans, originated in 2017 to 2020, are transitional or under construction and may not yet be income producing. Certain ratios, such as loan to value and debt service coverage ratios, may not be evaluated as the value of the underlying transitional property significantly fluctuates based on completion of the project.
Net
Book Value of Commercial Mortgage Loans Receivable by Year of Origination
Less
allowance for credit losses on the investment pool
(i827)
Less allowance for credit losses on individual loans
i—
Carrying
value, net of valuation allowance
$
i141,843
/
As of June
30, 2022, the Company evaluated the commercial mortgage loan portfolio on a pool basis to determine the allowance for credit losses. At the end of the period, the Company had i20 loans in the portfolio. For the six months ended June 30, 2022, the allowance for credit losses increased $i282
thousand. The provision for credit losses is included in "Realized gains (losses)" in the Condensed Consolidated Statements of Operations.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
iNote
5—Commitments and Contingencies
Guarantees: The Parent Company has guaranteed letters of credit in connection with its credit facility with a group of banks. The letters of credit were issued by TMK Re, Ltd., a wholly-owned subsidiary, to secure TMK Re, Ltd.’s obligation for claims on certain policies reinsured by TMK Re, Ltd. that were sold by other Globe Life insurance subsidiaries. These letters of credit facilitate TMK Re, Ltd.’s ability to reinsure the business of Globe Life's insurance carriers. The agreement was amended on September 30, 2021 and now expires in 2026. The maximum amount of letters of
credit available is $i250 million. The Parent Company would be liable to the extent that TMK Re, Ltd. does not pay the reinsured party. The amount outstanding at June 30, 2022 was $i125
million.
Litigation: Globe Life Inc. (formerly Torchmark Corporation) and its subsidiaries, in common with the insurance industry in general, are subject to litigation, including putative class action litigation, alleged breaches of contract, torts, including bad faith and fraud claims based on alleged wrongful or fraudulent acts of agents of the Parent Company's insurance subsidiaries, employment discrimination, worker misclassification, and miscellaneous other causes of action. Based
upon information presently available, and in light of legal and other factual defenses available to the Parent Company and its subsidiaries, management does not believe that it is reasonably possible that such litigation will have a material adverse effect on Globe Life's financial condition, future operating results or liquidity; however, assessing the eventual outcome of litigation necessarily involves forward-looking speculation as to judgments to be made by judges, juries and appellate courts in the future. This bespeaks caution, particularly in states with reputations for high punitive damage verdicts. Globe Life's management recognizes that large punitive damage awards bearing little or no relation to actual damages continue to be awarded by juries in jurisdictions in which the Parent Company's insurance subsidiaries
have substantial business, creating the potential for unpredictable material adverse judgments in any given punitive damage suit.
On July 22, 2022, putative class and collective action litigation was filed against Arias Agencies and American Income Life Insurance Company (“American Income”) (collectively, “Defendants”) in United States District Court for the Western District of Pennsylvania (David Burkes v. Arias Agencies and American Income Life Insurance Company, Case No. 2:22-cv-1054). The complaint alleges that insurance agent trainees should have been classified as employees, and after contracting should have been classified as employees instead of independent contractors. Plaintiff David Burkes is a former Pennsylvania independent sales agent and asserts claims under Pennsylvania
law on behalf of a putative class of all individuals who trained to become and/or worked as sales agents for American Income in the three years prior to July 22, 2022 through case conclusion. Burkes makes claims (a) under the Pennsylvania Minimum Wage Act and the Pennsylvania Wage Payment and Collection Law for the alleged failure to pay minimum wage, alleged failure to pay for time spent in training, alleged failure to pay for missed meals and rest breaks, allegedly requiring putative class members to pay for work-related expenses, and allegedly subjecting putative class members to “chargebacks”; (b) for unjust enrichment for allegedly benefiting from the uncompensated labor of putative class members; and (c) for the rescission of putative class members’ agent contracts. Burkes also asserts a collective action on behalf
of the same group of individuals for minimum wage, overtime, liquidated damages, and attorney’s fees and costs under the Fair Labor Standards Act for the three years prior to July 22, 2022 through case conclusion, as well as a claim that American Income allegedly did not keep accurate records of hours worked by sales agents. American Income intends to vigorously dispute the individual and class and collective claims, including enforcing the class action waiver and right to individual arbitration found in agent contracts, which has been recognized by other federal courts in Pennsylvania.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
i
Note
7—Postretirement Benefits
Globe Life has qualified noncontributory defined benefit pension plans (Pension Plans) and contributory savings plans that cover substantially all employees. There is also a nonqualified noncontributory supplemental executive retirement plan (SERP) that covers a limited number of officers. The tables included herein will focus on the Pension Plans and SERP.
(1)A
fund including marketable securities that mirror the S&P 500 index.
(2)Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan.
(3)Included in other long-term investments is an investment fund that reports the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value per share or its equivalent (NAV), as a practical expedient for fair value. The Globe Life Inc. Pension Plan owns less than i1%
of the investment fund. As of June 30, 2022, the expected term of the investment fund is approximately i3 years and the commitment of the investment is fully funded. The investment is non-redeemable.
(1)A
fund including marketable securities that mirror the S&P 500 index.
(2)Representing a guaranteed annuity contract issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan.
(3)Included in other long-term investments is an investment fund that reports the Globe Life Inc. Pension Plan's pro-rata share of the limited partnership's net asset value per share or its equivalent (NAV), as a practical expedient for fair value. The Globe Life Inc. Pension Plan owns approximately i1%
of the investment fund. As of December 31, 2021, the expected term of the investment fund was approximately i3 years and the commitment of the investment is fully funded. The investment is non-redeemable.
SERP: iThe
following table includes information regarding the SERP.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Pension Plans and SERP Liabilities: iThe
following table presents liabilities for the defined benefit pension plans and SERP at June 30, 2022 and December 31, 2021.
Net
Periodic Benefit Cost:iThe following table presents the net periodic benefit costs for the Pension Plans and SERP by expense components for the three and six months ended June 30, 2022 and 2021.
Earnings per Share: iA reconciliation of basic and diluted weighted-average shares outstanding used in the computation of basic and diluted earnings per share is as follows:
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
iNote
9—Debt
On May 19, 2022, Globe Life completed the issuance of $i400 million principal amount of i4.8%
Senior notes due June 15, 2032, of which $i150 million is owned by Globe Life affiliates. Total proceeds received by the Parent from the issuance, net of the underwriters’ discount, were $i395
million. The proceeds will be used to fund $i300 million of i3.8% Senior notes maturing on September 15, 2022, as well as
for the reduction of commercial paper and other general corporate purposes.
i
The following table presents information about the terms and outstanding balances of Globe Life's debt.
(1)An
additional $i150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation.
The commercial paper has the highest priority of all the debt, followed by senior notes then junior subordinated debentures. The senior notes due 2023 are noncallable, the remaining senior notes are callable under a make-whole provision, and the junior subordinated debentures are
subject to an optional redemption ifive years from issuance. Interest on the i4.25% junior subordinated debentures is payable quarterly while all other long-term debt is payable
semi-annually.
Federal Home Loan Bank (FHLB) Funding: In2021, four of our insurance subsidiaries became members of the FHLB of Dallas. FHLB membership provides the insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. The membership requires ownership of FHLB common stock, as well as the purchase of activity-based common stock equal to approximately 4.1% of outstanding borrowings.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
Globe Life owns $i11.3
million in FHLB common stock as of June 30, 2022 and $i7.9 million as of December 31, 2021. The FHLB stock is restricted for the duration of the membership and recorded at cost (par) as required by applicable guidance. The FHLB stock is included in "Other long-term investments" in theCondensed
Consolidated Balance Sheetsand activity is recorded in "Net receipts (payments) from deposit-type products" in the Condensed Consolidated Statement of Cash Flows.
As of June 30, 2022, there were ino outstanding borrowings with the FHLB. Borrowings with the FHLB are subject
to the availability of pledged assets at Globe Life. As of June 30, 2022, Globe Life's maximum borrowing capacity under the FHLB facility was approximately $i545 million, based on pledged assets with a fair value of $i638
million.
iNote 10—Business Segments
Globe Life is organized into ifour
segments: life insurance, supplemental health insurance, annuities, and investments. In addition, other expenses not included in these segments are reported in "Corporate & Other."
Globe Life's reportable insurance segments are based on the insurance product lines it markets and administers: life insurance, supplemental health insurance, and annuities. These major product lines are set out as reportable segments because of the common characteristics of products within these categories, comparability of margins, and the similarity in regulatory environment and management techniques. There is also an investment segment which manages the investment portfolio, debt, and cash flow for the insurance segments and the corporate function. The Company's chief operating decision makers evaluate the overall performance
of the operations of the Company in accordance with these segments.
Life insurance products marketed by Globe Life include traditional whole life and term life insurance. An immaterial amount of annuities sold as companion products are included in the life segment. Health insurance products are generally guaranteed renewable and include Medicare Supplement, critical illness, accident, and limited-benefit supplemental hospital and surgical coverage. Annuities include fixed-benefit contracts.
Globe Life markets its insurance products through a number of distribution channels, each of which sells the products of one or more
of Globe Life's insurance segments. Our distribution channels consist of the following exclusive agencies: American Income Life Division (American Income), Liberty National Division (Liberty National) and Family Heritage Division (Family Heritage); an independent agency, United American Division (United American); and our Direct to Consumer Division (Direct to Consumer). The following tables present segment premium revenue by each of Globe Life's distribution channels.
Due
to the nature of the life insurance industry, Globe Life has no individual or group that would be considered a major customer. Substantially all of Globe Life's business is conducted in the United States.
The measure of profitability established by the chief operating decision makers for the insurance segments is underwriting margin before other income and administrative expenses, in accordance with the manner in which the segments are managed. It essentially represents gross profit margin on insurance products before insurance administrative expenses and consists primarily of premium less net policy benefits, acquisition expenses, and commissions. Required interest on net policy liabilities (benefit reserves less deferred acquisition costs) is reflected as a component of the Investment segment (rather than as a component of underwriting margin in the insurance
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
and annuity segments) in order to match this cost with the investment income earned on the assets supporting the net policy liabilities.
The measure of profitability for the Investment segment is excess investment income, representing the income earned on the investment portfolio in excess of net policy requirements and financing costs associated with Globe Life's debt. Other
than the above-mentioned interest allocations, no other intersegment revenues or expenses are recognized. Expenses directly attributable to corporate operations are included in the “Corporate & Other” category. Stock-based compensation expense is considered a corporate expense by Globe Life management and is included in this category. All other unallocated revenues and expenses on a pretax basis, including insurance administrative expense, are also included in the “Corporate & Other” segment category.
Globe Life holds a sizable investment portfolio to support its insurance liabilities, the yield from which is used to offset policy benefit, acquisition, administrative and tax expenses. This yield or investment income is taken into account when establishing premium rates and profitability expectations for its insurance products. From time to time, investments
are sold or called, or experience a credit loss event, each of which is reflected by the Company as realized gain (loss)—investments. These gains or losses generally occur as a result of disposition due to issuer calls, compliance with Company investment policies, or other reasons often beyond management’s control. Unlike investment income, realized gains and losses are incidental to insurance operations, and only overall yields are considered when setting premium rates or insurance product profitability expectations. While these gains and losses are not relevant to segment profitability or core operating results, they can have a material positive or negative result on net income. For these reasons, management removes realized investment gains and losses when it views its segment operations.
Management
removes items that are related to prior periods when evaluating the operating results of current periods. Management also removes non-operating items unrelated to the Company's core insurance activities when evaluating those results. Therefore, these items are excluded in its presentation of segment results, because accounting guidance requires that operating segment results be presented as management views its business. With the exception of the administrative settlements noted in the paragraphs above, all of these items are included in “Other operating expense” in the Condensed Consolidated Statements of Operations for the appropriate year. See additional detail below in the tables.
Notes to Condensed Consolidated Financial Statements
(Dollar amounts in thousands, except per share data)
i
The
following tables set forth a reconciliation of Globe Life's revenues and operations by segment to its major income statement line items. See Note—1 Significant Accounting Policies for additional information concerning reconciling items of segment profits to pretax income.
Notes to Condensed Consolidated Financial Statements
(Dollar
amounts in thousands, except per share data)
The following tables set forth a reconciliation of Globe Life's revenues and operations by segment to its major income statement line items. See Note—1 Significant Accounting Policies for additional information concerning reconciling items of segment profits to pretax income.
We caution readers regarding certain forward-looking statements contained in the foregoing discussion and elsewhere
in this document, and in any other statements made by, or on behalf of Globe Life whether or not in future filings with the Securities and Exchange Commission. Any statement that is not a historical fact, or that might otherwise be considered an opinion or projection concerning the Company or its business, whether express or implied, is meant as and should be considered a forward-looking statement. Such statements represent management's opinions concerning future operations, strategies, financial results or other developments. We specifically disclaim any obligation to update or revise any forward-looking statement because of new information, future developments, or otherwise.
Forward-looking statements are based upon estimates and assumptions that are subject to significant business, economic
and competitive uncertainties, many of which are beyond our control, including uncertainties related to the impact of the COVID-19 pandemic and associated direct and indirect effects on our business operations, financial results and financial condition. If these estimates or assumptions prove to be incorrect, the actual results of Globe Life may differ materially from the forward-looking statements made on the basis of such estimates or assumptions. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:
1.Economic
and other conditions, including the impact of inflation and the COVID-19 pandemic on the U.S. economy, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and utilization of health care services that differ from Globe Life's assumptions;
2.Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement);
3.Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance;
5.General economic, industry sector or individual debt issuers’ financial conditions (including developments and volatility arising from the COVID-19 pandemic, particularly in certain industries that may comprise part of our investment portfolio) that may affect the current market value of securities we own, or that may impair an issuer’s ability to make principal and/or interest payments due on those securities;
6.Changes in the competitiveness of the Company's products and pricing;
7.Litigation results;
8.Levels of administrative and
operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from operating during the COVID-19 pandemic and the impact of higher than anticipated inflation);
9.The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;
10.The customer response to new products and marketing initiatives;
11.Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;
12.Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility
to, our computer and other information technology systems;
13.The severity, magnitude and impact of natural or man-made catastrophic events, including but not limited to pandemics, tornadoes, hurricanes, earthquakes, war and terrorism, on our operations and personnel, commercial activity and demand for our products; and
14.Our ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period.
Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission.
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with Globe Life's Condensed Consolidated Financial Statements
and Notes thereto appearing elsewhere in this report. The following management discussion will only include comparison to prior year.
"Globe Life" and the "Company" refer to Globe Life Inc. and its subsidiaries and affiliates.
Results of Operations
How
Globe Life Views Its Operations. Globe Life Inc. is the holding company for a group of insurance companies that market primarily individual life and supplemental health insurance to lower middle to middle-income households throughout the United States. We view our operations by segments, which are the insurance product lines of life, supplemental health, and annuities, and the investment segment that supports the product lines. Segments are aligned based on their common characteristics, comparability of the profit margins, and management techniques used to operate each segment.
Insurance
Product Line Segments. The insurance product line segments involve the marketing, underwriting, and administration of policies. Each product line is further segmented by the various distribution channels that market the insurance policies. Each distribution channel operates in a niche market offering insurance products designed for that particular market. Whether analyzing profitability of a segment as a whole, or the individual distribution channels within the segment, the measure of profitability used by management is the underwriting margin, as seen below:
Premium revenue
(Policy obligations)
(Policy
acquisition costs and commissions)
Underwriting margin
Investment Segment.The investment segment involves the management of our capital resources, including investments and the management of corporate debt and liquidity. Our measure of profitability for the investment segment is excess investment income, as seen below:
As discussed in further detail within Note 2—New Accounting Standards, the Company will adopt ASU 2018-12, Financial Services–Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (LDTI), effective on January 1, 2023. The Company has selected the modified retrospective transition method upon adoption as of the transition date (the “Transition
Date”) of January 1, 2021. The accounting adoption will have no economic impact on the cash flows of our business nor influence our business model of providing basic protection-oriented products to the underserved and lower middle to middle-income market. In addition, the adoption will not impact our statutory earnings, statutory capital, nor our capital management philosophies.
It will, however, modify the timing of when profits emerge on our insurance policies and result in the restatement of 2021 and 2022 key figures in the consolidated financial statements. We are anticipating GAAP net income and net operating income to increase significantly under the new standard primarily due to a reduction in DAC amortization in the near or intermediate term. Additionally, future policy benefits on our life insurance business for 2021 and 2022, as restated
to reflect the new standard, are expected to be lower than originally reported reflecting the treatment of adverse claims experience incurred in 2021 and 2022, which gets spread out over future periods from transition, including those relating to COVID-19. The expected decrease in future policy benefits related to this item in 2021 is expected to be within $160 million and $200 million, and the impact on 2022 has not yet been quantified. This will result in slightly higher future policy benefits, as a percentage of premium, in future years than what would have been expected under existing guidance. Finally, we expect some modest decreases to future policy benefits, as a percentage of premium, in our health business on some of our limited benefit plans under the new standard.
With respect to future policy benefits, we anticipate an increase of between $9.5 billion and $11.0 billion on the Transition
Date, which will be reflected in other comprehensive income. This change reflects an unrealized interest rate loss at transition and is a result of several primary factors:
a.Life insurance future policy benefit cash flows tend to be long as death benefits, which are greater than premium amounts, are typically paid to beneficiaries many years after a policy is issued. This results in a generally longer overall liability duration than the overall asset duration.
b.The new methodology requires the use of current discount rates (upper-medium grade) rather than locked-in discount rates, which are determined when a policy is issued. Current discount rates are generally lower than the locked-in discount rates used to determine net income. The required current discount rate is inconsistent with historical practices, the current asset portfolio
and current investment strategy.
c.The methodology requires the net premium ratio1 used to determine future policy benefits be based on locked-in rates rather than permitting the redetermination of the net premium ratio using current discount rates. This restricts the level of gross premiums allowed in the calculation, as well as the level of gross premiums available to offset the impact of current discount rates to the extent these rates are realized in future years. Because of this requirement, the change in future policy benefits, at transition, results in a measure of unrealized gain (loss) due to differences in discount rates only.
For Globe Life, discount rates lower than the locked-in discount rate under LDTI have the effect of significantly increasing the level
of reserves carried due to the use of net premiums in the calculation as compared to current GAAP, which in the loss recognition test, uses the total gross premium cash flows. Once implemented, future policy benefits will be sensitive to changes in current discount rates for the reasons stated above. To demonstrate this sensitivity to discount rates, to the extent current discount rates were consistent with rates as of June 30, 2022, we estimate future policy benefits would have only increased between $3.0 billion and $4.0 billion. For every 50 basis-point movement in the average discount rate, we estimate the impact on future policy benefits is $1.5 billion to $2.5 billion.
With respect to shareholders’ equity, as of the end of 2020, reported shareholders’ equity on the Consolidated Balance Sheets was $8.8 billion. We anticipate a decrease
in the range of $7.5 billion to $8.5 billion, net of tax, as a result of the requirement to use current discount rates to remeasure the future policy benefits and record the offset through AOCI at adoption. If we hold all else equal as of the Transition Date but use current discount rates as of June 30, 2022, the after-tax decrease in AOCI due solely to the increase in future policy benefits would have been in the range of $2.4 billion to $3.2 billion. AOCI would also be impacted by fluctuations in the valuation of the fixed maturity bond portfolio in this situation.
__________________________
1The net premium ratio is the ratio between the present value of benefits and the present value of gross premium.
Another item impacting shareholders’ equity relates to increases in the liability for future policy benefits on smaller, older blocks of business with a minimum floor or net premium ratios capped at 100%. The Company uses the net premium ratio as of the Transition Date (using locked-discount rates) to calculate the liability for future policy benefits using two different discount rates: 1) the discount rate used immediately before the Transition Date (locked-in discount rates), and 2) the
discount rate determined by reference to the Transition Date market level yields for upper-medium grade (low credit risk) fixed income instruments. For blocks of business that require increases in future policy benefits to minimum levels, or a net premium ratio capped at 100% on the Transition Date, any difference between the future policy benefits calculated using the discount rate immediately before the Transition Date, and the existing carrying value as of the Transition Date is recorded as an adjustment (decrease) to opening retained earnings. At the Transition Date, we expect a $15 million to $50 million, net of tax, decrease to opening retained earnings related to these items.
As noted above, we expect GAAP net income and net operating income to increase under the new standard due to a significant decrease in the annual amortization of DAC in the near and intermediate term. This is a result
of changes to the calculation of amortization rate, including use of only deferred costs through the valuation date. For business with deferrals of renewal commissions, as is the case with our captive agency channels, the expected amortization rate as a percentage of premium will no longer be level, but will increase over the period of time during which commissions are deferred. The decrease in amortization in the near term will primarily impact our life insurance line of business. In total, we expect the increase in net income due to the decrease in amortization to fall within a range of $120 million and $145 million, net of tax. As time progresses, we expect this impact to diminish as the deferral of future renewal commissions increases amortization amounts.
Regarding our measure of excess investment income, we expect a significant decrease in the figure as a result of the updated standard. This
is driven by the removal of interest discounting in the computation of amortization of DAC. Further, it is important to note that this change also influences the decrease in DAC amortization previously noted. Although non-GAAP measures, the review of underwriting margin and excess investment income will remain an important part of the Company’s measurement of performance.
Current Highlights, comparing year-to-date 2022 with 2021.
•Net income as a return on equity (ROE) for the six months ended June 30, 2022 was 9.8% and net operating income as an ROE, excluding net unrealized gains or losses on the fixed maturity portfolio(1) was 12.6%.
•Total premium increased 6% over the prior year. Life premium increased 5% for the period from $1.4 billion in 2021 to $1.5 billion in 2022. Life underwriting margin increased 10% from $315 million in 2021 to $348 million in 2022.
•Net investment income increased 3% over the same period in the prior year. Excess investment income
declined 1% below the prior year.
•Total net sales increased 5% over the same period in the prior year from $347 million in 2021 to $366 million in 2022.
•Book value per share declined 35% below the same period in the prior year from $83.59 to $54.18. Book value per share, excluding net unrealized gains or losses on the fixed maturity portfolio(1), increased 9% over the prior year from $55.66 in 2021 to $60.71 in 2022.
•The Company incurred $45 million of COVID-19 net life claims (net of reserves released upon death) for the six months ended June 30, 2022 compared with $49 million during
the same period last year.
•For the six months ended June 30, 2022, the Company repurchased 2.3 million shares of Globe Life Inc. common stock at a total cost of $223 million for an average share price of $98.22.
The following graphs represent net income and net operating income for the six month periods ended June 30, 2022 and 2021.
(1)As
shown in the charts above, net operating income is the consolidated total of segment profits after tax and as such is considered a non-GAAP measure. It has been used consistently by Globe Life's management for many years to evaluate the operating performance of the Company. It differs from net income primarily because it excludes certain non-operating items such as realized gains and losses and certain significant and unusual items included in net income. Net income is the most directly comparable GAAP measure.
Net operating income as an ROE, excluding net unrealized gains or losses on the fixed maturity portfolio, is considered a non-GAAP measure. Management utilizes this measure to view the business without the effect of the net unrealized gains or losses, which are primarily attributable to fluctuation in interest rates on the available-for-sale
portfolio. The impact of the adjustment to exclude net unrealized gains or losses on fixed maturities, net of tax is $(642) million and $2.9 billion for the six months ended June 30, 2022 and 2021, respectively.
Book value per share, excluding net unrealized gains or losses on the fixed maturity portfolio, is also considered a non-GAAP measure. Management utilizes this measure to view the book value of the business without the effect of net unrealized gains or losses, which are primarily attributable to fluctuation in interest rates on the available-for-sale portfolio. The impact of the adjustment to exclude net unrealized gains or losses on fixed maturities is $(6.53) and $27.93 for the six months ended June 30, 2022 and 2021,
respectively.
Summary
of Operations. Net income declined 10% to $341 million during the six months ended June 30, 2022, compared with $378 million in the same period in 2021. This decrease was primarily attributed to $30 million of after-tax realized losses on investments in the current period, as compared to $29 million of after tax realized gains on investments in the year-ago period. See further discussion under the caption Investments. On a diluted per common share basis, net income per common share for the six months ended June 30, 2022 declined 5% from $3.62 to $3.43.
Net operating income is the consolidated total of segment profits after
tax and as such is considered a non-GAAP measure. Net income is the most directly comparable GAAP measure. We do not consider realized gains and losses to be a component of our core insurance operations or operating segments. Additionally, net income was affected by certain significant and unusual non-operating items in 2021 and through the six months ended June 30, 2022. We do not view these items as components of core operating results because they are not indicative of past performance or future prospects of the insurance operations. We remove items such as these that relate to prior periods or are non-operating items when evaluating the results of current operations, and therefore exclude such items from our segment analysis for current periods. Net operating income increased 6% to $375 million for the six months ended June 30, 2022, compared with $353 million for
the same period in 2021, primarily due to a 10% increase in life underwriting margin. On a diluted per common share basis, net operating income per common share for the six months ended June 30, 2022 increased from $3.38 to $3.76.
Despite headwinds with COVID-19, the Company continues to see positive signs in its core operations, including strong sales and premium growth, favorable persistency and a strong ROE, excluding net unrealized gains or losses on the fixed maturity portfolio.
COVID-19. For the six months ended June
30, 2022, the Company incurred $45 million of COVID-19 net life claims (net of reserves released upon death), compared with $49 million for the same period in 2021. Per the Centers for Disease Control and Prevention (CDC), there were approximately 185 thousand U.S. COVID-19 deaths for the six months ended June 30, 2022 including 30 thousand deaths in the current quarter. For the full year 2022, we expect total U.S. COVID deaths to fall within a range of 215,000 to 275,000.
At the midpoint of our 2022 guidance, we expect to incur approximately $62 million of COVID life claims for the full year based on an estimated range of $2.4 million to $2.6 million of COVID life claims per 10,000 U.S. deaths. The projected life claims are dependent on this estimate and many
other variables, including, but not limited to, projected U.S. deaths from COVID-19, the timing and availability of effective treatments for the disease, vaccination rates and effectiveness of vaccines, impact from potential variants, and the ages and geographic areas in which infections and deaths occur.
Globe Life's operations on a segment-by-segment basis are discussed in depth below. Net operating
income has been used consistently by management for many years to evaluate the operating performance of the Company and is a measure commonly used in the life insurance industry. It differs from GAAP net income primarily because it excludes certain non-operating items such as realized gains and losses and other significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.
The life insurance segment is our primary segment and is the largest contributor to earnings in each period presented. The life insurance segment underwriting margin increased $33 million compared with the prior year six month period due to growth in premiums. The health segment contributed to the growth in income as well, contributing
$159 million of underwriting margin in the first six months of 2022 compared with $147 million in the first six months of 2021.
In 2022, the largest contributor of total underwriting margin was the life insurance segment and the primary distribution channel was American Income Life Division. The following charts represent
the breakdown of total underwriting margin by operating segment and distribution channel for the six months ended June 30, 2022.
Total premium income rose 6% for the six months ended June 30, 2022 to $2.2 billion. Total net sales increased 5% to $366 million, when compared with 2021. Total first-year collected premium (defined in the following section) was $293 million for 2022, compared with $288 million for 2021.
Life insurance premium
income increased 5% to $1.5 billion over the prior-year total of $1.4 billion. Life net sales rose 5% to $279 million for the first six months of 2022. First-year collected life premium was flat at $211 million. Life underwriting margins, as a percent of premium, increased to 23% in 2022 from 22%. Underwriting margin increased to $348 million in 2022, 10% over the same period in 2021.
Health insurance premium income increased 8% to $636 million over the prior-year total of $590 million. Health net sales rose 6% to $87 million for the first six months of 2022. First-year collected health premium rose 6% to $82 million. Health underwriting margins, as a percent of premium, were 25% in 2022 and 2021. Health underwriting margin increased to $159 million for the first six months of 2022, 8% over the same period in 2021.
Excess
investment income, the measure of profitability of our investment segment, declined 1% during 2022 to $118.8 million from $120.5 million in the same period in 2021. Excess investment income per common share, reflecting the impact of our share repurchase program, increased 3% to $1.19 from $1.15 when compared with the same period in 2021.
Insurance administrative expenses increased 9% in 2022 when compared with the prior-year period. These expenses were 6.8% as a percent of premium during 2022 compared with 6.6% a year earlier.
For the six months ended June 30, 2022, the Company repurchased 2.3 million Globe Life Inc. shares at a total cost of $223 million for an average share price
of $98.22.
The discussions of our segments are presented in the manner we view our operations, as described in Note 10—Business Segments.
We
use three statistical measures as indicators of premium growth and sales over the near term: “annualized premium in force,”“net sales,” and “first-year collected premium.”
•Annualized premium in force is defined as the premium income that would be received over the following twelve months at any given date on all active policies if those policies remain in force throughout the twelve-month period. Annualized premium in force is an indicator of potential growth in premium revenue.
•Net sales, a statistical performance measure, is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period has expired. Management
considers net sales to be a better indicator of the rate of premium growth than annualized premium issued.
•First-year collected premium is defined as the premium collected during the reporting period for all policies in their first policy year. First-year collected premium takes lapses into account in the first year when lapses are more likely to occur, and thus is a useful indicator of how much new premium is expected to be added to premium income in the future.
See further discussion of the distribution channels below for Life and Health.
Life insurance is the Company's predominant segment. During 2022, life premium represented 70% of total premium and life underwriting margin represented 68% of the total underwriting margin. Additionally, investments supporting the reserves for life products produce the majority of excess investment income attributable to the investment segment.
The
following table presents the summary of results of life insurance. Further discussion of the results by distribution channel is included below.
Life Insurance
Summary of Results
(Dollar amounts in thousands)
Six
Months Ended June 30,
Change
2022
2021
Amount
% of Premium
Amount
% of Premium
Amount
%
Premium and policy
charges
$
1,514,526
100
$
1,436,289
100
$
78,237
5
Policy
obligations
1,060,377
70
1,016,102
71
44,275
4
Required interest on reserves
(381,431)
(25)
(362,420)
(25)
(19,011)
5
Net
policy obligations
678,946
45
653,682
46
25,264
4
Commissions, premium taxes, and non-deferred acquisition expenses
126,090
8
115,478
8
10,612
9
Amortization
of acquisition costs
361,486
24
351,728
24
9,758
3
Total expense
1,166,522
77
1,120,888
78
45,634
4
Insurance
underwriting margin
$
348,004
23
$
315,401
22
$
32,603
10
The higher life insurance underwriting margins, as well as the higher underwriting margins as a percentage
of premium, for the six months ended June 30, 2022 are largely due to the increase in premium growth.
The following table presents Globe Life's life insurance premium by distribution channel.
Life Insurance
Premium by Distribution Channel
(Dollar amounts in thousands)
Six
Months Ended June 30,
Increase (Decrease)
2022
2021
Amount
% of Total
Amount
% of Total
Amount
%
American
Income
$
746,406
49
$
682,591
48
$
63,815
9
Direct to Consumer
500,491
33
493,468
34
7,023
1
Liberty
National
162,170
11
153,590
11
8,580
6
Other
105,459
7
106,640
7
(1,181)
(1)
Total
$
1,514,526
100
$
1,436,289
100
$
78,237
5
Annualized life premium in force was $3.02 billion at June 30, 2022, an increase of 6%
over $2.86 billion a year earlier.
An analysis of life net sales, an indicator of new business production, by distribution channel is presented below.
Life Insurance
Net
Sales by Distribution Channel
(Dollar amounts in thousands)
Six Months Ended June 30,
Increase (Decrease)
2022
2021
Amount
%
of Total
Amount
% of Total
Amount
%
American Income
$
170,514
61
$
142,856
54
$
27,658
19
Direct
to Consumer
66,529
24
81,972
31
(15,443)
(19)
Liberty National
36,625
13
34,148
13
2,477
7
Other
4,955
2
5,635
2
(680)
(12)
Total
$
278,623
100
$
264,611
100
$
14,012
5
First-year collected life premium
by distribution channel is presented in the table below.
Life Insurance
First-Year Collected Premium by Distribution Channel
(Dollar amounts in thousands)
Six
Months Ended June 30,
Increase (Decrease)
2022
2021
Amount
% of Total
Amount
% of Total
Amount
%
American
Income
$
131,908
63
$
121,432
58
$
10,476
9
Direct to Consumer
46,656
22
60,878
29
(14,222)
(23)
Liberty
National
28,001
13
23,747
11
4,254
18
Other
4,731
2
4,763
2
(32)
(1)
Total
$
211,296
100
$
210,820
100
$
476
—
A discussion of life operations
by distribution channel follows.
The American Income Life Division markets to members of labor unions and continues to diversify its lead sources by building relationships with other affinity groups, utilizing third-party internet vendor leads, and obtaining referrals to facilitate sustainable growth. This division is Globe Life's largest contributor to life premium of any distribution channel at 49% of the Company's June 30, 2022 total. Net sales increased 19% to $171 million during the first six months of 2022 compared with $143 million in 2021 for the same period. The underwriting margin, as a percent of premium, was 32% for the six months ended June 30, 2022,
up from 30% in the year-ago period.
This division incurred $14 million in COVID-19 net life claims, representing approximately 2% of premium, for the six months ended June 30, 2022 compared with $13 million in COVID-19 net life claims during the year-ago period.
This
division is anticipating an increase in net sales for the full year 2022 as compared with 2021 due in part to increased productivity plus an improvement in issue rates as some challenges in underwriting, such as staffing and speed of obtaining medical records and other information, are resolving. The average producing agent count is based on the actual count at the end of each week during the year. Recruiting challenges in a difficult job market led to a reduction in the number of producing agents in the second half of 2021. The division is seeing improvements in the job market and its ability to recruit both virtually and in-person and currently expects growth in the producing agent count in the second half of 2022. Sales growth in this division, as well as within our other exclusive agencies, is generally dependent on growth in the size of the agency force.
Below is the average producing
agent count year-to-date for the American Income Life Division.
At June 30,
Change
2022
2021
Amount
%
American
Income
9,528
10,198
(670)
(7)
American Income Life continues to focus on growing and strengthening the agency force, specifically through emphasis on agency middle-management growth and additional agency office openings. In addition to offering financial
incentives and training opportunities, the agency has made considerable investments in information technology, including launching a customer relationship management (CRM) tool for the agency force. This tool is designed to drive productivity in lead distribution, conservation of business, manager dash boards and new agent recruiting. Additionally, this division has invested in and successfully implemented technology that allows the agency force to engage in virtual recruiting, training and sales activity. Over the course of the pandemic, the agents have shifted to primarily a virtual experience with the customers and have generated a vast majority of its sales through virtual presentations. We find this flexibility to be enticing for new recruits as well as a driver of sustainability for our agency force.
The Direct to Consumer Division
(DTC) offers adult and juvenile life insurance through a variety of marketing approaches, including direct mailings, insert media, and electronic media. In recent years, production from electronic media, which is comprised of sales through both the internet and inbound phone calls to our call center, has grown faster than direct mail response as customer demand increased marketing activity to internet and mobile technology. The proportion of sales from the internet and inbound phone calls had been steadily increasing prior to COVID-19, but accelerated after the start of the pandemic. The different approaches support and complement one another in the division's efforts to reach the consumer. The DTC's long-term growth has been fueled by constant innovation and name recognition. We continually introduce new initiatives in this division in an attempt to increase response rates.
While the
juvenile market is an important source of sales, it is also a vehicle to reach the parents and grandparents of juvenile policyholders, who are more likely to respond favorably to a DTC solicitation for life coverage on themselves in comparison to the general adult population. Also, future offerings to juvenile policyholders and their parents are sources of low acquisition-cost life insurance sales in the future.
DTC net sales declined 19% to $67 million for the six months ended June 30, 2022 compared with $82 million for the same period in the prior year, due to the record high net life sales in the prior year. The decline is also due in part to the impact of recent record inflation on the cost of our direct mailings and on our customers, who generally have less discretionary income to purchase and retain life insurance. DTC incurred
$23 million of COVID-19 net life claims, representing approximately 5% of premium, for the six months ended June 30, 2022 compared with $25 million for the same period in 2021. DTC’s underwriting margin, as a percent of premium, was 8% for the six months ended June 30, 2022 and 9% for the same period in 2021.
The Liberty National Division markets individual life insurance to middle-income household and worksite customers. Recent investments in new sales technologies as well as recent growth in middle management within the agency are expected to help continue this growth. The underwriting margin as a percent of premium was 19% for the six months ended June 30, 2022, up from 17% during the
same period a year ago. This increase is primarily attributable to lower net policy obligations in relation to premium during the six months ended June 30, 2022 compared with the same period a year ago. This division incurred $6 million of COVID-19 net life claims, representing approximately 4% of premium, for the six months ended June 30, 2022 compared with $9 million, or 6% of premium for the same period in 2021.
Net sales rose 7% in the six months ended June 30, 2022 over the same period in 2021. With the division's ability to return to face-to-face customer interaction and the option of virtual sales, the Company continues to project total net life sales to increase for the remainder of 2022 as compared to the prior year.
Below is the average producing agent count year-to-date for the Liberty National Division.
At
June 30,
Change
2022
2021
Amount
%
Liberty National
2,685
2,717
(32)
(1)
The
Liberty National Division average producing agent count decreased 1% compared with the prior-year comparable period. We continue to execute our long-term plan to grow this agency through expansion from small-town markets in the Southeast to more densely populated areas with larger pools of potential agent recruits and customers. Continued expansion of this agency’s presence into more heavily populated, less-penetrated areas will help create long-term agency growth. Additionally, the agency continues to help improve the ability of agents to develop new worksite marketing business. Systems that have been put in place, including the addition of a CRM platform and enhanced analytical capabilities, have helped the agents develop additional worksite marketing opportunities as well as improve the productivity of agents selling in the individual life market. As the division continues to gain momentum in its sales and recruiting initiatives and advances its technology and CRM
platform, the agency anticipates an increase in recruiting of new agents and an increase in the average producing agent count.
The Other Agencies distribution channels primarily include non-exclusive independent agencies selling predominantly life insurance. The Other Agencies contributed $105 million of life premium income, or 7% of Globe Life's total premium income in the six months ended June 30, 2022, and contributed 2% of net sales for the period.
HEALTH INSURANCE
Health insurance sold by the
Company primarily includes Medicare Supplement insurance, accident coverage, and other limited-benefit supplemental health products including cancer, critical illness, heart, and intensive care coverage.
Health premium accounted for 30% of our total premium in 2022, while the health underwriting margin accounted for 31% of total underwriting margin. Health underwriting margin increased 8% to $159 million primarily due to higher premium growth. The Company continues to emphasize life insurance sales relative to health due to life’s superior long-term profitability and its greater contribution to excess investment income.
The following table presents underwriting margin data for health insurance.
Health Insurance
Summary of Results
(Dollar amounts in thousands)
Six
Months Ended June 30,
Change
2022
2021
Amount
% of Premium
Amount
% of Premium
Amount
%
Premium
$
636,189
100
$
589,759
100
$
46,430
8
Policy
obligations
394,073
62
376,683
64
17,390
5
Required interest on reserves
(54,103)
(9)
(50,429)
(9)
(3,674)
7
Net
policy obligations
339,970
53
326,254
55
13,716
4
Commissions, premium taxes, and non-deferred acquisition expenses
58,305
9
46,486
8
11,819
25
Amortization
of acquisition costs
79,098
13
70,378
12
8,720
12
Total expense
477,373
75
443,118
75
34,255
8
Insurance
underwriting margin
$
158,816
25
$
146,641
25
$
12,175
8
Globe
Life markets supplemental health insurance products through a number of distribution channels. The following table is an analysis of our health premium by distribution channel.
Health Insurance
Premium by Distribution Channel
(Dollar amounts in thousands)
Six
Months Ended June 30,
Increase (Decrease)
2022
2021
Amount
% of Total
Amount
% of Total
Amount
%
United
American
$
267,457
42
$
233,304
40
$
34,153
15
Family Heritage
180,298
28
168,347
29
11,951
7
Liberty
National
93,841
15
94,158
16
(317)
—
American Income
58,246
9
56,140
9
2,106
4
Direct
to Consumer
36,347
6
37,810
6
(1,463)
(4)
Total
$
636,189
100
$
589,759
100
$
46,430
8
Premium
related to limited-benefit plans comprise $347 million, or 55%, of the total health premiums for 2022 compared with $308 million in the same period in the prior year. Premium from Medicare Supplement products comprises the remaining $289 million, or 45%, for 2022 compared with $282 million, or 48%, in the same period in the prior year.
Annualized health premium in force was $1.3 billion at June 30, 2022, an increase of 8% over $1.2 billion a year earlier.
Presented below is a table of health net sales by distribution channel.
Health Insurance
Net Sales by Distribution Channel
(Dollar amounts in thousands)
Six
Months Ended June 30,
Increase (Decrease)
2022
2021
Amount
% of Total
Amount
% of Total
Amount
%
United
American
$
25,347
29
$
25,027
30
$
320
1
Family Heritage
38,007
44
34,744
42
3,263
9
Liberty
National
13,037
15
12,053
15
984
8
American Income
9,428
11
9,277
11
151
2
Direct
to Consumer
1,063
1
1,226
2
(163)
(13)
Total
$
86,882
100
$
82,327
100
$
4,555
6
Health
net sales related to limited-benefit plans comprise $64 million, or 73%, of the total health net sales for 2022 compared with $56 million, or 68%, in the same period in the prior year. Medicare Supplement sales make up the remaining $23 million, or 27%, for 2022 compared with $26 million, or 32%, in the same period in the prior year.
The following table presents health insurance first-year collected premium by distribution channel.
Health Insurance
First-Year Collected Premium by Distribution Channel
(Dollar amounts in thousands)
Six
Months Ended June 30,
Increase (Decrease)
2022
2021
Amount
% of Total
Amount
% of Total
Amount
%
United
American
$
31,003
38
$
28,702
37
$
2,301
8
Family Heritage
29,596
36
28,165
36
1,431
5
Liberty
National
11,126
13
9,847
13
1,279
13
American Income
8,711
11
9,334
12
(623)
(7)
Direct
to Consumer
1,467
2
1,581
2
(114)
(7)
Total
$
81,903
100
$
77,629
100
$
4,274
6
First-year
collected premium related to limited-benefit plans comprise $53 million, or 64%, of total first-year collected premium for 2022 compared with $47 million, or 61%, in the same period in the prior year. First-year collected premium from Medicare Supplement policies makes up the remaining $29 million, or 36%, for 2022 compared with $30 million, or 39%, in the same period in the prior year.
A discussion of health operations by distribution channel follows.
The United American Division consists of non-exclusive independent agencies who may also sell for other companies. The United American Division was Globe Life's largest health agency in terms of health premium income.
This
division is also Globe Life's largest producer of Medicare Supplement insurance. The United American Division represents 83% of all Medicare Supplement premium and 95% of Medicare Supplement net sales. For the six months ended June 30, 2022, Medicare Supplement premium in this agency rose 5% to $240 million in 2022 over the prior period total of $229 million. Medicare Supplement net sales declined 11% to $22 million in 2022 from the prior-year period, primarily as a result of a decrease in individual sales. Underwriting margin as a percent of premium was 15% for the six months ended June 30, 2022, down from 16% in 2021.
The Family Heritage Division primarily markets limited-benefit supplemental health insurance in non-urban areas. Most of its policies include a cash-back feature, such as a return of premium, where any excess of premiums over claims paid is returned to the policyholder at the end of a specified period stated within the insurance policy. Underwriting margin as a percent of premium was 27% for the six months ended June 30, 2022, up from 26% in the year-ago period.
The division experienced a 9% increase in net health sales as compared with the six-month period a year ago, primarily due
to an increase in agent productivity and training. The division will continue to launch incentive programs to help drive an increase in productivity and the number of producing agents.
Below is the average producing agent count year-to-date for the Family Heritage Division. While the agency has seen a decrease in agent count as compared with 2021, the division did have an increase in agent count during the second quarter. We anticipate that as COVID-19 and the job market stabilizes, agent recruitment opportunities should increase.
At
June 30,
Change
2022
2021
Amount
%
Family Heritage Division
1,137
1,253
(116)
(9)
The
Liberty National Division represented 15% of all Globe Life health premium income for the six-month period ended June 30, 2022. The Liberty National Division markets limited-benefit supplemental health products, consisting primarily of critical illness insurance. Much of Liberty National's health business is generated through worksite marketing targeting small businesses. Health premium at Liberty National Division was $94 million for the six months ended June 30, 2022, and 2021. Liberty National's first-year collected premium rose 13% to $11.1 million in the six months ended June 30, 2022 compared with $9.8 million for the same period in 2021. Health net sales for the six months ended June
30, 2022 rose 8% from the comparable period in 2021. We anticipate an increase in net health sales going forward as this division becomes more able to interact face-to-face with customers.
Other Distribution.The Company's other distribution channels, while primarily focused on selling life insurance, also market health products. The American Income Life Division primarily markets accident plans. The Direct to Consumer Division primarily markets Medicare Supplements to employer or union-sponsored groups. On a combined basis, these other channels accounted for 15% of health premium for the six months ended June 30, 2022 and 2021.
ANNUITIES
Annuities
represent an insignificant part of our business. We do not currently market stand-alone fixed or deferred annuity products, favoring instead protection-oriented life and supplemental health insurance products.
We
manage our capital resources including investments, debt, and cash flow through the investment segment. Excess investment income represents the profit margin attributable to investment operations and is the measure that we use to evaluate the performance of the investment segment as described in Note 10—Business Segments. It is defined as net investment income less both the required interest on net insurance policy liabilities and the interest cost associated with capital funding or “financing costs.”
Management also views excess investment income per diluted common share as an important and useful measure to evaluate the performance of the investment segment. It is defined as excess investment income divided by the total diluted weighted
average shares outstanding, representing the contribution by the investment segment to the consolidated earnings per share of the Company. Since implementing our share repurchase program in 1986, we have used $8.9 billion of excess cash flow at the Parent Company to repurchase Globe Life Inc. common shares after determining that the repurchases provided a greater risk adjusted after-tax return than other investment alternatives. If we had not used this excess cash to repurchase shares, but had instead invested it in interest-bearing assets, we would have earned more investment income and had more shares outstanding. As excess investment income per diluted common share incorporates all capital resources, we view excess investment income per diluted common share as a useful measure to evaluate the investment segment.
Excess
Investment Income. The following table summarizes Globe Life's investment income, excess investment income, and excess investment income per diluted common share.
Analysis of Excess Investment Income
(Dollar amounts in thousands, except for per share data)
Six
Months Ended June 30,
Change
2022
2021
Amount
%
Net investment income
$
487,476
$
474,128
$
13,348
3
Interest
on net insurance policy liabilities:
Interest on reserves
(454,876)
(432,870)
(22,006)
5
Interest on deferred acquisition costs
128,002
122,192
5,810
5
Net
required interest
(326,874)
(310,678)
(16,196)
5
Financing costs
(41,772)
(42,947)
1,175
(3)
Excess
investment income
$
118,830
$
120,503
$
(1,673)
(1)
Excess investment income per diluted share
$
1.19
$
1.15
$
0.04
3
Mean
invested assets (at amortized cost)
$
19,540,396
$
18,748,877
$
791,519
4
Average net insurance policy liabilities(1)
11,284,565
10,838,913
445,652
4
Average
debt and preferred securities (at amortized cost)
2,173,444
1,966,285
207,159
11
(1)Net of deferred acquisition costs, excluding the associated unrealized gains and losses thereon.
Excess investment income declined $1.7 million, or 1%, compared with the year-ago period. Excess investment income per diluted common share was $1.19 for the six months ended June
30, 2022 an increase of 3% over the prior year period. Excess investment income per diluted common share generally increases at a faster pace than excess investment income because the number of diluted shares outstanding generally decreases from year to year as a result of our share repurchase program.
Net investment income for the six months ended June 30, 2022 was $487 million or 3% greater than the year-ago period. Mean invested assets increased 4% during the first six months of 2022 over the same period last year. The effective annual yield rate earned on the fixed maturity portfolio was 5.16% in the first six months of 2022, compared with 5.24% a year earlier. Growth in net investment income has
been negatively impacted in recent years by the low
interest rate environment. Generally, investment income grows at a slower rate than the assets when the yield on new investments is lower than the yield on dispositions or the average portfolio yield. It also increases at a faster rate than the assets when new investment yields exceed the yield on dispositions or the average portfolio yield. We currently
expect that the average annual turnover rate of fixed maturity assets will be less than 2% over the next five years and will not have a material negative impact on net investment income. In addition to fixed maturities, the Company has also invested in limited partnerships with debt like characteristics that diversify risk and enhance risk-adjusted, capital-adjusted returns on the portfolio. The earned yield on the investment funds for the six months ended June 30, 2022 was 5.56%. See additional information in Note 4—Investments. For the full year 2022, we currently anticipate the average new money rate on our fixed maturity acquisitions to be approximately 150 basis points higher than the yield
achieved on our 2021 acquisitions. This expected increase in yields should result in the investment income growth rate being closer to the growth of our invested assets.
Globe Life's net investment income benefits from higher interest rates on new investments. While increasing interest rates have resulted in a net unrealized loss on the fixed maturities portfolio as of June 30, 2022, we are not concerned because we do not generally intend to sell, nor is it likely that we will be required to sell, the fixed maturities prior to their anticipated recovery.
Required interest on net insurance policy liabilities
reduces net investment income, as it is the amount of net investment income considered by management necessary to “fund” required interest on net insurance policy liabilities, which is the net of the benefit reserve liability and the deferred acquisition cost asset. As such, it is removed from the investment segment and applied to the insurance segments to offset the effect of the required interest from the insurance segments. As discussed in Note 10—Business Segments, management regards this as a more meaningful analysis of the investment and insurance segments. Required interest is based on the actuarial interest assumptions used in discounting the benefit reserve liability and the amortization of deferred acquisition costs for our insurance policies in force.
The
great majority of our life and health insurance policies are fixed interest rate protection policies, not investment products, and are accounted for under current GAAP accounting guidance for long-duration insurance products which mandate that interest rate assumptions for a particular block of business be “locked in” for the life of that block of business. Each calendar year, we set the discount rate to be used to calculate the benefit reserve liability and the amortization of the deferred acquisition cost asset for all insurance policies issued that year. That rate is based on the new money yields that we expect to earn on cash flow received in the future from policies of that issue year and cannot be changed. The discount rate used for policies issued in the current year has no impact on the in force policies issued in prior years as the rates of all prior issue years are also locked in. As such, the overall discount rate for the entire in force block of 5.8%
is a weighted average of the discount rates being used from all issue years. Changes in the overall weighted-average discount rate over time are caused by changes in the mix of the reserves and the deferred acquisition cost asset by issue year on the entire block of in force business. Business issued in the current year has very little impact on the overall weighted-average discount rate due to the size of our in force business. In 2023, new guidance will become effective that will significantly impact the accounting for our long duration contracts including the determination of required interest. Please see Note 2—New
Accounting Standards for additional information.
Since actuarial discount rates are locked in for life on essentially all of our business, benefit reserves and deferred acquisition costs are not affected by interest rate fluctuations unless a loss recognition event occurs. Due to the strength of our underwriting margins, we do not expect an extended low interest rate environment will cause a loss recognition event.
In comparison to the year-ago period, required interest on net insurance policy liabilities increased $16 million, or 5%, to $327 million, compared with the 4% growth in average net interest-bearing insurance policy liabilities.
Financing costs for the investment segment consist primarily of interest on our various debt instruments. The table below presents the components of financing costs and reconciles interest expense per the Consolidated Statements of Operations.
Analysis
of Financing Costs
(Dollar amounts in thousands)
Six Months Ended June 30,
Increase (Decrease)
2022
2021
Amount
%
Interest
on funded debt
$
38,745
$
40,126
$
(1,381)
(3)
Interest on short-term debt
3,027
2,821
206
7
Financing
costs
$
41,772
$
42,947
$
(1,175)
(3)
During the first six months of 2022, financing costs decreased 3% compared with the prior year primarily due to lower overall rates on the funded debt. More information on our debt transactions is disclosed in the Financial
Condition section of this report.
Realized Gains and Losses.Our life and health insurance companies collect premium income from
policyholders for the eventual payment of policyholder benefits, sometimes paid many years or even decades in the future. Since benefits are expected to be paid in future periods, premium receipts in excess of current expenses are invested to provide for these obligations. For this reason, we hold a significant investment portfolio as a part of our core insurance operations. This portfolio consists primarily of high-quality fixed maturities containing an adequate yield to provide for the cost of carrying these long-term insurance product obligations. As a result, fixed maturities are generally held for long periods to support these obligations. Expected yields on these investments are taken into account when setting insurance premium rates and product profitability expectations.
Despite our intent to hold fixed maturity investments for a long period of time, investments are occasionally
sold, exchanged, called, or experience a credit loss event, resulting in a realized gain or loss. Gains or losses are only secondary to our core insurance operations of providing insurance coverage to policyholders. In a bond exchange offer, bondholders may consent to exchange their existing bonds for another class of debt securities. The Company also has investments in certain limited partnerships, held under the fair value option, with fair value changes recognized in Realized gains (losses) in the Consolidated Statements of Operations.
Realized gains and losses can be significant in relation
to the earnings from core insurance operations, and as a result, can have a material positive or negative impact on net income. The significant fluctuations caused by gains and losses can cause period-to-period trends of net income that are not indicative of historical core operating results or predictive of the future trends of core operations. Accordingly, they have no bearing on core insurance operations or segment results as we view operations. For these reasons, and in line with industry practice, we remove the effects of realized gains and losses when evaluating overall insurance operating results.
The following table summarizes our tax-effected realized gains (losses) by component.
Analysis of Realized Gains (Losses), Net of Tax
(Dollar amounts in thousands,
except for per share data)
(1)During the six months ended June 30, 2022 and 2021, the Company recorded $1.9 million and $108.3 million of exchanges of fixed maturity
securities (noncash transactions) that resulted in $0 and $19.9 million, respectively, in realized gains, net of tax.
As investment yields increased in the first six months of 2022, the Company disposed of certain fixed maturity investments to reinvest in higher-grade fixed maturities and to improve the risk-adjusted, capital-adjusted returns on the portfolio. These sales resulted in realized losses for the six months ended June 30, 2022.
Investment Acquisitions. Globe Life's investment policy calls for investing primarily in investment grade fixed maturities that meet our quality and yield objectives. We generally invest in securities with longer maturities because they more closely match the long-term nature of our policy liabilities. We believe this strategy is appropriate since our expected future cash flows are generally stable and predictable and the likelihood that we will need to sell invested assets to raise cash is low.
The
following table summarizes selected information for fixed maturity investments. The effective annual yield shown is based on the acquisition price and call features, if any, of the securities. For non-callable bonds, the yield is calculated to maturity date. For callable bonds acquired at a premium, the yield is calculated to the earliest known call date and call price after acquisition ("first call date"). For all other callable bonds, the yield is calculated to maturity date.
(1)Fixed maturity acquisitions included unsettled trades of $36 million in 2022 and $0 in 2021.
(2)Tax-equivalent
basis, where the yield on tax-exempt securities is adjusted to produce a yield equivalent to the pretax yield on taxable securities.
For investments in callable bonds, the actual life of the investment will depend on whether the issuer calls the investment prior to the maturity date. Given our investments in callable bonds, the actual average life of our investments cannot be known at the time of the investment. Absent sales and "make-whole calls", however, the average life will not be less than the average life to next call and will not exceed the average life to maturity. Data for both of these average life measures is provided in the above chart.
Acquisitions in both periods consisted primarily of corporate and municipal bonds with securities spanning a diversified range of issuers, industry
sectors, and geographical regions. In the first six months of 2022, we invested primarily in the municipal, financial and industrial sectors. For the entire portfolio, the taxable equivalent effective yield earned was 5.16%, down approximately 8 basis points from the yield in the first six months of 2021. As previously noted in the discussion of net investment income, the decrease was primarily due to the combination of lower interest rates applicable to new purchases and fixed maturity dispositions. For the remainder of 2022, the Company will continue to execute on its existing strategy by seeking to invest in assets that satisfy our quality and other objectives, while maximizing the highest risk-adjusted capital-adjusted return.
Since fixed maturities represent such a significant portion of our investment portfolio, the remainder of the discussion of portfolio composition will focus on fixed maturities. See a breakdown of the Company's Other long-term investments in Note
4—Investments.
Selected information concerning the fixed maturity portfolio is as follows:
Credit Risk Sensitivity. The following tables summarize certain information about the major corporate sectors and security types held in our fixed maturity portfolio at June 30, 2022 and December 31, 2021.
Corporate securities, which consist of bonds and redeemable preferred stocks, were the largest component of the June 30, 2022 fixed maturity portfolio, representing 82% of amortized cost, net and 83% of fair value. The remainder of the portfolio is invested primarily
in securities issued by the U.S. government and U.S. municipalities. The Company holds insignificant amounts in foreign government bonds, collateralized debt obligations, asset-backed securities, and mortgage-backed securities. Corporate securities are diversified over a variety of industry sectors and issuers. At June 30, 2022, the total fixed maturity portfolio consisted of 923 issuers.
Fixed maturities had a fair value of $17.2 billion at June 30, 2022, compared with $21.3 billion at December 31, 2021. The net unrealized gain (loss) position in the fixed-maturity portfolio decreased from a $3.5 billion gain position at December
31, 2021 to a loss position of $814 million at June 30, 2022 due to an increase in market rates during the period.
For more information about our fixed maturity portfolio by component at June 30, 2022 and December 31, 2021, including a discussion of allowance for credit losses, an analysis of unrealized investment losses and a schedule of maturities, see Note 4—Investments.
An analysis of the fixed maturity
portfolio by a composite quality rating at June 30, 2022 and December 31, 2021, is shown in the following tables. The composite rating for each security, other than private-placement securities managed by third parties, is the average of the security’s ratings as assigned by Moody’s Investor Service, Standard & Poor’s, Fitch Ratings, and Dominion Bond Rating Service, LTD. The ratings assigned by these four nationally recognized statistical rating organizations are evenly weighted when calculating the average. The composite quality rating is created utilizing a methodology developed by Globe Life using ratings from the various rating agencies noted above. The composite quality rating is not a Standard & Poor's credit rating. Standard & Poor's does not sponsor, endorse or promote the composite quality rating and shall not be liable for any use of the composite
quality rating. Included in the following chart are private placement fixed maturity holdings of $516 million at amortized cost, net of allowance for credit losses ($493 million at fair value) for which the ratings were assigned by the third-party managers.
Average Composite Quality Rating on Amortized Cost
Investment grade:
AAA
$
761,526
4
$
867,728
4
AA
2,215,179
13
2,412,947
11
A
4,487,607
25
5,584,588
26
BBB+
3,779,051
21
4,616,977
22
BBB
4,289,044
24
5,174,667
24
BBB-
1,570,969
9
1,865,241
9
Total
investment grade
17,103,376
96
20,522,148
96
A-
Below investment grade:
BB
537,064
3
583,608
3
B
128,402
1
136,026
1
Below
B
36,080
—
63,505
—
Total below investment grade
701,546
4
783,139
4
BB-
$
17,804,922
100
$
21,305,287
100
Weighted
average composite quality rating
A-
The overall quality rating of the portfolio is A-, the same as year-end 2021. Fixed maturities rated BBB are 53% of the total portfolio at June 30, 2022 compared with 54% at year-end 2021, and the percentage of BBB bonds to the overall portfolio has been declining since the end of 2018. While this ratio is high relative to our peers, we have limited exposure to higher-risk assets such as derivatives, equities, and asset-backed securities. Additionally, the Company does not participate in securities lending and has no off-balance sheet investments as of June 30, 2022. Of our fixed
maturity purchases, BBB securities generally provide the Company with the best risk-adjusted, capital-adjusted returns largely due to our ability to hold securities to maturity regardless of fluctuations in interest rates or equity markets.
An analysis of changes in our portfolio of below-investment grade fixed maturities at amortized cost, net of allowance for credit losses is as follows:
Our investment policy calls for investing
primarily in fixed maturities that are investment grade and meet our quality and yield objectives. Thus, any increases in below-investment grade issues are typically a result of ratings downgrades of existing holdings. Below-investment grade bonds at amortized cost, net of allowance for credit losses, were 10% of our shareholders’ equity, excluding the effect of unrealized gains or losses on fixed maturities as of June 30, 2022. Globe Life invests long term and as such, one of our key criterion in our investment process is to select issuers that have the ability to weather multiple financial cycles.
OPERATING EXPENSES
Operating expenses are included
in the "Corporate and Other" segment and are classified into two categories: insurance administrative expenses and expenses of the Parent Company. Insurance administrative expenses generally include expenses incurred after a policy has been issued. As these expenses relate to premium for a given period, management measures the expenses as a percentage of premium income. The Company also views stock-based compensation expense as a Parent Company expense. Expenses associated with the issuance of our insurance policies are reflected as acquisition expenses and included in the determination of underwriting margin.
Total
operating expenses for the first six months increased 9% over the prior year period reflecting higher insurance administrative expenses. Insurance administrative expenses increased $13 million primarily due to higher information technology costs, including associated information technology salaries, higher employee costs in general, and higher costs due to the addition of Globe Life Benefits. Insurance administrative expenses as a percent of premium were 6.8%, compared to 6.6% for the same period in 2021. The non-operating expenses relate to a lease termination that occurred during the quarter.
Globe Life has an ongoing share repurchase program that began in 1986, and is reviewed with the Board of Directors by management quarterly and annually reaffirmed by the Board of Directors. With no specified authorization amount, we determine the amount of repurchases based on the amount of the excess cash flows after the payment of dividends to the Parent Company shareholders, general market conditions, and other alternative uses. Excess cash flow at the Parent Company is primarily comprised of dividends received from the insurance
subsidiaries less interest expense paid on its debt and other limited operating activities. The majority of our share repurchases are made from excess cash flow after the payment of shareholder dividends. Additionally, when stock options are exercised, proceeds from these exercises and the resulting tax benefit are used to repurchase additional shares on the open market to minimize dilution as a result of the option exercises. On August 4, 2021, the Board of Directors reauthorized the Parent Company’s share repurchase program in amounts and with timing that management, in consultation with the Board, determines to be in the best interest of the Company and its shareholders.
The
following chart summarizes share repurchases for the six month periods ended June 30, 2022 and 2021.
Throughout
the remainder of this discussion, share repurchases will only refer to those made from excess cash flow at the Parent Company.
FINANCIAL CONDITION
Liquidity. Liquidity provides Globe Life with the ability to meet on demand the cash commitments required to support our business operations and meet our financial obligations. Our liquidity is primarily derived from multiple sources: positive cash flow from operations, a portfolio of marketable securities, a revolving credit facility, commercial paper and the Federal Home Loan Bank (FHLB).
Insurance Subsidiary Liquidity. The
operations of our insurance subsidiaries have historically generated substantial cash inflows in excess of immediate cash needs. Cash inflows for the insurance subsidiaries primarily include premium and investment income. In addition to investment income, maturities and scheduled repayments in the investment portfolio are cash inflows. Cash outflows from operations include policy benefit payments, commissions, administrative expenses, and taxes. A portion of the excess cash inflows in the current year will provide for the payment of future policy benefits and are invested primarily in long-term fixed maturities as they better match the long-term nature of these obligations. Excess cash available from the insurance subsidiaries’
operations is generally distributed as a dividend to the Parent Company, subject to regulatory restrictions. The dividends are generally paid in amounts equal to the subsidiaries’ prior year statutory net income excluding realized capital gains. While the leading source of the excess cash is investment income, a significant portion of the excess cash also comes from underwriting income due to our high underwriting margins and effective expense control. While the insurance subsidiaries annually generate more operating cash inflows than cash outflows, the companies also have the entire available-for-sale fixed maturity investment portfolio available to create additional cash flows if required.
Four of our insurance subsidiaries are members of the FHLB of Dallas. FHLB membership provides the insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. While not the only source of liquidity, the FHLB could provide the insurance subsidiaries
with an additional source of liquidity, if needed. Refer to Note 9—Debt for further details.
Parent Company Liquidity. An important source of Parent Company liquidity is the dividends from its insurance subsidiaries. These dividends are received throughout the year and are used by the Parent Company to pay dividends on common and preferred stock, interest and principal repayment requirements on Parent Company debt, and operating expenses of the Parent Company.
Dividends from subsidiaries and excess cash flows are projected to be lower in 2022 primarily due to higher COVID life losses and the growth in our exclusive agency sales in 2021, both of which resulted in lower cash flows generated by the affiliates to the Parent. Additional sources of liquidity for the Parent Company are cash, intercompany receivables, intercompany
borrowings, public debt markets, term loans, and a revolving credit facility. At June 30, 2022, the Parent Company had access to $318 million of invested cash, net intercompany receivables and other liquid assets.
Short-Term Borrowings. An additional source of Parent Company liquidity is a credit facility with a group of lenders allowing for unsecured borrowings and stand-by letters of credit up to $750 million, which could be extended up to $1 billion. While the Parent Company may request the extension, it is not guaranteed. Up to $250 million in letters of credit can be issued against the facility. The facility serves as a back-up line of credit for a commercial paper program under which commercial
paper may be issued at any time, with total commercial paper outstanding not to exceed the facility maximum, less any letters of credit issued. Interest charged on the commercial paper program resembles variable rate debt due to its short term nature. On September 30, 2021, Globe Life amended the credit agreement dated August 24, 2020. The five-year credit agreement will now mature on September 30, 2026. As of June 30, 2022, the Parent Company was in full compliance with all covenants related to the aforementioned debt.
As a part of the credit facility, Globe Life has stand-by letters of credits. These letters of credit are issued on behalf of our insurance subsidiaries.
The
following table presents certain information about our commercial paper borrowings.
Average balance of commercial paper outstanding during period (par value)
$
369,468
$
297,901
Daily-weighted average interest rate (annualized)
0.69
%
0.24
%
Maximum
daily amount outstanding during period (par value)
$
500,529
$
355,000
The Company reduced the commercial paper borrowings by $150 million since year-end, utilizing a portion of the proceeds from the issuance of a new senior debt offering. See Note 9—Debt
for more information regarding this offering. We had no difficulties in accessing the commercial paper market under this facility during the six months ended June 30, 2022 and 2021.
Globe Life expects to have readily available funds for 2022 and the foreseeable future to conduct its operations and to maintain target capital ratios in the insurance subsidiaries through liquid assets currently available, internally-generated cash flow and the credit facility. In the unlikely event that more liquidity is needed, the Parent Company could generate additional funds through multiple sources including, but not limited to, the issuance of debt, an additional short-term credit facility or term loan, and intercompany
borrowing.
Consolidated Liquidity. Consolidated net cash inflows from operations were $693 million in the first six months of 2022, compared with $702 million in the same period of 2021. The decrease is primarily attributable to fluctuations in the settlement of certain amounts included in other liabilities. In addition to cash inflows from operations, our insurance companies received proceeds from dispositions of fixed maturities available for sale in the amount of $306 million during the 2022 period. As previously noted under the caption Credit Facility, the Parent Company has
in place a revolving credit facility. The insurance companies have no additional outstanding credit facilities.
Cash and short-term investments were $288 million at June 30, 2022, compared with $161 million at December 31, 2021. In addition to these liquid assets, the entire $17.2 billion (fair value at June 30, 2022) portfolio of fixed income securities is available for sale in the event of an unexpected need. Approximately 97% of our fixed income securities are publicly traded, freely tradable under SEC Rule 144, or qualified for resale under SEC Rule 144A. We generally expect to hold fixed income securities to maturity, and even though these securities are classified as available for sale, we have the ability and general intent to hold
any securities to recovery. Our strong cash flows from operations, on-going investment maturities, and available liquidity under our credit facility make any need to sell securities for liquidity highly unlikely.
Capital
Resources.The Parent Company's capital structure consists of short-term debt (the commercial paper facility and current maturities of long-term debt), long-term debt, and shareholders’ equity.
Long-Term Borrowings. The outstanding long-term debt at book value was $1.6 billion at June 30, 2022 and $1.5 billion at December 31, 2021. Refer to Note 9—Debt for a complete analysis and description of
long-term debt issues outstanding.
(1)An additional $150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation.
Subsidiary
Capital: The National Association of Insurance Commissioners (NAIC) has established a risk-based factor approach for determining threshold risk-based capital levels for all insurance companies. This approach was designed to assist the regulatory bodies in identifying companies that may require regulatory attention. A Risk-Based Capital (RBC) ratio is typically determined by dividing adjusted total statutory capital by the amount of risk-based capital determined using the NAIC’s factors. If a company’s RBC ratio approaches two times the RBC amount, the company must file a plan with the NAIC for improving its capital levels (this level is commonly referred to as “Company Action Level” RBC). Companies typically hold a multiple of the Company Action
Level RBC depending on their particular business needs and risk profile.
Our goal is to maintain statutory capital within our insurance subsidiaries at levels necessary to support our current ratings. For 2022, Globe Life has targeted a consolidated Company Action Level RBC ratio of 300% to 320%. The Company concludes that this capital level is more than adequate and sufficient to support its current ratings, given the nature of its business and its risk profile. As of December 31, 2021, our consolidated Company Action Level RBC ratio was 315%. The Parent Company is committed to maintaining the targeted consolidated RBC ratio at its insurance subsidiaries
and has sufficient liquidity available to provide additional capital if necessary.
Shareholders' Equity: On May 17, 2022, the Parent Company announced that it had declared a quarterly dividend of $0.2075 per share. This dividend was paid on August 1, 2022.
Shareholders’ equity was $5.3 billion at June 30, 2022. This compares with $8.6 billion at December 31, 2021 and $8.6 billion at June 30, 2021. During the six months since December 31, 2021, shareholders’ equity decreased primarily due to $3.4 billion of after-tax unrealized losses in the fixed-maturity portfolio as interest rates have increased over the period. In addition, shareholders' equity increased by net income of $341 million during the first six months of 2022, but was offset by share repurchases of $223 million and an
additional $41 million in share purchases to offset the dilution from stock option exercises.
We plan to use excess cash available at the Parent Company as efficiently as possible in the future. Possible uses of excess cash flow include, but are not limited to, share repurchases, acquisitions, shareholder dividend payments, investments in securities, or repayment of short-term debt. We will determine the best use of excess cash after ensuring that targeted capital levels are maintained in our insurance subsidiaries. If market conditions are favorable, we currently expect that share repurchases will continue to be a primary use of those funds.
Globe Life is required under GAAP to revalue its available for sale fixed
maturity portfolio to fair market value at the end of each accounting period. These changes, net of their associated impact on deferred acquisition costs and income tax, are reflected directly in shareholders’ equity. Fluctuations in interest rates cause undue volatility in the period-to-period presentation of our shareholders’ equity, capital structure, and financial ratios. Due to the long-term nature of our fixed maturity investments and policy liabilities and the strong cash flows consistently generated by our insurance subsidiaries, we have the ability to hold our securities to maturity. As such, we do not expect to incur losses due to fluctuations in market value of fixed maturities caused by market rate changes and temporarily illiquid markets. Accordingly, our management, credit rating agencies, lenders, many industry analysts, and certain other financial statement users
prefer to remove the effect of this accounting rule when analyzing our balance sheet, capital structure, and financial ratios.
The following table presents selected data related to our capital resources. Additionally, the table presents the effect
of this accounting guidance on relevant line items, so that investors and other financial statement users may determine its impact on Globe Life's capital structure. Excluding the effect of unrealized gains or losses on the fixed maturity portfolio from shareholders' equity is considered non-GAAP. Below we include the reconciliation to GAAP.
Selected Financial Data
(Dollar amounts in thousands, except per share data)
(1)Amount
added to (deducted from) comprehensive income to produce the stated GAAP item, per accounting rule ASC 320-10-35-1.
(2)Includes the value of business acquired (VOBA).
(3)Globe Life's debt covenants require that the effect of this accounting rule be removed to determine this ratio. This ratio is computed by dividing total debt by the sum of total debt and shareholders’ equity.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no quantitative or qualitative changes with respect to market risk exposure during the six months ended June 30, 2022.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and
Procedures: Globe Life, under the direction of the Co-Chairmen and Chief Executive Officers and the Senior Executive Vice President and Chief Financial Officer, has established disclosure controls and procedures that are designed to ensure that information required to be disclosed by Globe Life in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. The disclosure controls and procedures are also intended to ensure that such information is accumulated and communicated to Globe Life's management, including the Co-Chairmen and Chief Executive Officers and the Senior Executive Vice President and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.
As of the end of the fiscal period
completed June 30, 2022, an evaluation was performed under the supervision and with the participation of Globe Life management, including the Co-Chairmen and Chief Executive Officers and the Senior Executive Vice President and Chief Financial Officer, of the disclosure controls and procedures (as those terms are defined in Rule 13a-15(e) under the Securities Exchange Act of 1934). Based upon their evaluation, the Co-Chairmen and Chief Executive Officers and the Senior Executive Vice President and Chief Financial Officer have concluded that disclosure controls and procedures are effective as of the date of this Form 10-Q. In compliance with Section 302 of the Sarbanes Oxley Act of 2002 (18 U.S.C. § 1350), each of these officers executed a Certification included as an exhibit to this Form 10-Q.
Changes
in Internal Control over Financial Reporting: As of the period ended June 30, 2022, there have not been any changes in Globe Life Inc.'s internal control over financial reporting or in other factors that could significantly affect this control over financial reporting subsequent to the date of their evaluation which have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.
The
Company had no material changes to its risk factors.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Certain Equity Securities by the Issuer and Others for the Second Quarter of 2022
Period
(a) Total Number
of
Shares
Purchased
(b) Average
Price Paid
Per Share
(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(d) Maximum Number
of Shares (or
Approximate Dollar
Amount) that May
Yet Be Purchased
Under the Plans or
Programs
April
1-30, 2022
462,687
$
101.01
462,687
May 1-31, 2022
484,107
96.40
484,107
June 1-30,
2022
538,610
93.82
538,610
On August 4, 2021, the Globe Life Board of Directors reaffirmed its continued authorization of the Company's stock repurchase program in amounts and with timing that management, in consultation with the Board, determined to be in the best interest of the Company. The program
has no defined expiration date or maximum shares to be repurchased.
XBRL Instance Document- the instance document does not appear in the Interactive Data file because the XBRL tags are embedded within the Inline XBRL document.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
